Contact us (is on the right)

  1. Company
    1. About
    2. Services
  2. Media
    1. News blog
    2. Meet GCT team
  3. White papers
    1. Region and countries
    2. Therapeutic areas
  4. Services
    1. Site registration
    2. Patient information Center
  5. Website information
    1. Privacy policy
    2. Terms of service
    3. Site map
    4. Employees login

Get in touch

Call us:

Email: info@gctrials.com

Meet us at upcoming industry events

More: Offices, Career at GCT

Patients: Patient information Center

CRO Contract Research Organization with 15+ years expertise in Russia, Central and Eastern Europe


FDA/EMEA/GCP compliant clinical trials in all therapeutic areas, phases I-IV

Phase I-IV clinical trials conducted since 2001

Over 15,000 subjects enrolled

Excellence at enrollment

Projection vs actual enrollment for one of our recent studies

Trusted clinical data

Over 2/3 of all FDA/EMA approved drugs are studied in international trials involving Russia

Shortest regulatory timelines

Our regulatory track is 100% successfull

Headquarters in Princeton, NJ, USA

Six regional offices in CEEcovering Bulgaria, Czech Republic, Hungary, Romania, Russia, Slovakia and Ukraine

Explore coverage details

Head office, BD office
Princeton, NJ, USA

Phone: 1-609-921-6868
Contact details

Russian office, BD office in St. Petersburg

Phone: 7-812-703-0008
Country information
Contact details

Ukrainian office in Kiev

Phone: 38-044-501-9038
Country information
Contact details

Romanian office in Bucharest

Phone: 40-21-527-0380
Country information
Contact details

Bulgarian office in Sofia

Phone: 359-2-983-5358
Country information
Contact details

Central Europe office in Budapest

Phone: 36-30-353-7538
Hungary information
Czech Republic information
Slovakia information
Contact details

A full-service CRO

We will have you covered end-to-end throughout the trial

  • Study start-up
  • Regulatory services
  • Global, regional, local project management
  • Local safety, medical monitoring support
  • Clinical monitoring
  • Patient recruitment
  • Drug logistics
  • Data management and biostatistics
See a detailed list of our services

In the news

See all news

June 14, 2017

New cardiac surgery study is awarded to GCT

 

An innovative European pharmaceutical company appointed GCT for management of its international multi-center double-blind Phase III study in Russia.
According to the research made by the Sponsor, there are currently no drugs on the market that have been shown to reduce the risk of postoperative complications for patients undergoing invasive cardiac surgery. Therefore, if previously collected data is proved by this clinical trial, its implications will go far beyond the realm of cardiac surgery for patients, the community and pharma business.

May 19, 2017

RRMS study close-out meeting

 

GCT is proud to announce that Phase II clinical trial was successfully completed!
Last week Dr. Eugene Selivra, CEO, and Dr. Alexey Vinogradov, Project Manager, participated in the investigator meeting in Sochi, Russia devoted to the successful Phase II Multiple Sclerosis project completion. During the formal part of the meeting an overview of promising study results was given by the Sponsor and a dynamic discussion on the future application of the study drug took place. After the official part was over, all participants proceeded to a lavish gala-dinner organized by the Sponsor to celebrate the project success. Informal and very animated conversations continued, revolving around current standards of care, breakthrough therapies and market potential for the studied product.

April 12, 2017

GCT team completes project training with MAPI Group

As the start-up stage of an observational infant study is actively progressing, our multinational study team has attended a project-specific training held in Budapest by our colleagues from MAPI Group. GCT clinical department members from Russia, Ukraine and Hungary gathered to hold discussions on protocol-specific questions, study timelines and milestones overview, and a round table on enrollment strategies and investigator motivation tools.

The study is a follow up to an international Phase III clinical study in pre-term delivery which GCT is responsible for in CEE countries. The Sponsor for both projects has been our long-term partner, awarding studies to GCT since 2004. We believe this to be a perfect demonstration of the high quality of our work which maintains the trust of our clients for years and makes 80% of our business repeat.

Meet GCT team

Hear our clients

The management team and the CRAs are physicians, and the lead monitor for our breast cancer trial is an oncologist. The monitoring and reporting of the data are exceptional.

Senior Director, Clinical Operations,
US Pharma